Metraipolis › archive › dc_241ea0555486

Clinical translation of TLR agonist-modified silicified cancer cell therapy supported by humanized mouse models — Europe PMC PMID:41322193

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41322193
DOI
10.1016/j.omton.2025.201074
License (as archived)
solo-consultazione
Archived
2026-11-09T02:16:45.408Z
SHA-256 of the archived text
0eb0fe1aa745ada0c8ade7a14fb7b3c17bf3845897e40c7ae1cb5f3648914acf
Stable URL of this page
https://metraipolis.com/documento/dc_241ea0555486

How to cite

Clinical translation of TLR agonist-modified silicified cancer cell therapy supported by humanized mouse models — Europe PMC PMID:41322193 — Europe PMC (en), https://europepmc.org/article/MED/41322193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_241ea0555486 (Metraipolis archive dc_241ea0555486, sha256 0eb0fe1aa745ada0c8ade7a14fb7b3c17bf3845897e40c7ae1cb5f3648914acf)
BibTeX
@misc{dc241ea0555486,
  title = {Clinical translation of TLR agonist-modified silicified cancer cell therapy supported by humanized mouse models — Europe PMC PMID:41322193},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322193},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_241ea0555486; sha256 0eb0fe1aa745ada0c8ade7a14fb7b3c17bf3845897e40c7ae1cb5f3648914acf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322193. Agents can read the archived copy with the MCP tool read_document.